Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.

作者: Brijeshkumar Patel , Nilesh Gupta , Fakhrul Ahsan

DOI: 10.1089/JAMP.2013.1073

关键词: Low molecular weight heparinInflammationOvalbuminImmunologyAnti-asthmatic AgentAnti-inflammatoryDrug carrierPharmacologyChemistryHeparinAsthma

摘要: Abstract Background: Heparin-like compounds interrupt leukocyte adhesion and migration, prevent release of chemical mediators during the process inflammation. However, little is known whether anti-inflammatory property smaller heparin fragments, low-molecular-weight (LMWH), plays any role in airway In this study, we sought to evaluate efficacy LMWH-loaded large porous polyethylene glycol–poly(D,L-lactide-co-glycolide) (PEG-PLGA) particulate formulations alleviating cellular biochemical changes associated with asthma. Methods: To study pharmacological LMWH for treatment asthma, have used a previously optimized polymeric formulation LMWH. The anti-asthmatic was studied an ovalbumin-sensitized rat model influence on asthmatic lungs assessed by measuring total protein content number inflammatory cells bronchoalveolar ...

参考文章(40)
Carlos Campo, Jussara F. Molinari, Jaime Ungo, Tahir Ahmed, Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses Journal of Applied Physiology. ,vol. 86, pp. 549- 557 ,(1999) , 10.1152/JAPPL.1999.86.2.549
Pingli Li, Juzheng Sheng, Yuhong Liu, Juan Li, Jian Liu, Fengshan Wang, Heparosan‐Derived Heparan Sulfate/Heparin‐Like Compounds: One Kind of Potential Therapeutic Agents Medicinal Research Reviews. ,vol. 33, pp. 665- 692 ,(2013) , 10.1002/MED.21263
Judah Folkman, Yuen Shing, Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides Advances in Experimental Medicine and Biology. ,vol. 313, pp. 355- 364 ,(1992) , 10.1007/978-1-4899-2444-5_34
Giacomo Fontana, Mariano Licciardi, Silvana Mansueto, Domenico Schillaci, Gaetano Giammona, Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials. ,vol. 22, pp. 2857- 2865 ,(2001) , 10.1016/S0142-9612(01)00030-8
Susan S D'Souza, Patrick P DeLuca, None, Methods to Assess in Vitro Drug Release from Injectable Polymeric Particulate Systems Pharmaceutical Research. ,vol. 23, pp. 460- 474 ,(2006) , 10.1007/S11095-005-9397-8
Z Diamant, M C Timmers, H van der Veen, C P Page, F J van der Meer, P J Sterk, Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. American Journal of Respiratory and Critical Care Medicine. ,vol. 153, pp. 1790- 1795 ,(1996) , 10.1164/AJRCCM.153.6.8665036
CLAUDIA L ORDOÑEZ, Ramin Khashayar, Hofer H Wong, RON Ferrando, REEN Wu, Dallas M Hyde, Jon A Hotchkiss, Yifan Zhang, Alexander Novikov, Gregory Dolganov, John V Fahy, None, Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. American Journal of Respiratory and Critical Care Medicine. ,vol. 163, pp. 517- 523 ,(2001) , 10.1164/AJRCCM.163.2.2004039
D. BARAM, M. RASHKOVSKY, R. HERSHKOVIZ, I. DRUCKER, T. RESHEF, S. BEN-SHITRIT, Y. A. MEKORI, Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell‐dependent cutaneous inflammation Clinical and Experimental Immunology. ,vol. 110, pp. 485- 491 ,(1997) , 10.1046/J.1365-2249.1997.4541471.X
Vivek Gupta, Amit Rawat, Fakhrul Ahsan, Feasibility Study of Aerosolized Prostaglandin E1 Microspheres as a Noninvasive Therapy for Pulmonary Arterial Hypertension Journal of Pharmaceutical Sciences. ,vol. 99, pp. 1774- 1789 ,(2010) , 10.1002/JPS.21946